Worldwide patents have accumulated numbers to 155.
Worldwide patents have accumulated numbers to 152.
Worldwide patents have accumulated numbers to 151.
Worldwide patents have accumulated numbers to 150.
Worldwide patents have accumulated numbers to 149.
Worldwide patents have accumulated numbers to 148.
Worldwide patents have accumulated numbers to 144.
Worldwide patents have accumulated numbers to 143.
Worldwide patents have accumulated numbers to 142.
Worldwide patents have accumulated numbers to 139.
Worldwide patents have accumulated numbers to 138.
Worldwide patents have accumulated numbers to 137.
Worldwide patents have accumulated numbers to 136.
Worldwide patents have accumulated numbers to 133.
Worldwide patents have accumulated numbers to 129.
Worldwide patents have accumulated numbers to 126.
The clinical trial to evaluate the efficacy of GenMont functional probiotic for ameliorating bacterial vaginosis was completed.
Against Helicobacter pylori was published in an academic journal.
The beneficial effects of GenMont probiotics consumption on type 2 diabetes mellitus was published in an academic journal.
Worldwide patents have accumulated numbers to 115.
Aiding clinical improvement in children with asthma was published in an academic journal.
The clinical trial to evaluate the efficacy of GenMont functional probiotic for improving the skin conditions was completed.
“GenMont Osteo-Lac probiotic capsules” was approved as the first probiotic health food for bone health by TFDA.
Antiobesity effect of GenMont functional probiotic was published in an academic journal.
GenMont Biotech (China) was established in Wuqing science park, Tianjin
Anti-diabetes probiotics passed the clinical trial which conducted in Changhua Christian Hospital.
The effect of improvement Lupus erythematosus by GenMont functional probiotic was published in an academic journal.
10 worldwide patents are honored in 2017 and the accumulated numbers are more than 100 patents.
Hypolipidemic effect and improving metabolic function of Genmont functional probiotic was published again in an academic journal.
Hypolipidemic effect and improving metabolic function of Genmont functional probiotic was published again in an academic journal.
Genmont functional probiotic passed a large anti-AD clinical trial and the results were published in an academic journal.
Hypolipidemic effect of Genmont functional probiotic was published in an academic journal.
Hypolipidemic effect of Genmont functional probiotic was published in an academic journal.
Obtained factory TQF certificate.
“Genmont Meta-Pro capsules”was approved as the first probiotic health food for reducing body fat formation and adjuvant modulating blood lipids by TFDA.
“Tang-Mei-Le ADR-1 Probiotic capsules”was approved as the first probiotic health food for blood glucose regulation by TFDA.
Genmont functional probiotic passed a large anti-allergy clinical trial in Europe and the results were published in an academic journal.
Genmont eN-Lac Probiotic capsules was approval as Taiwan health food for immune modulation by TFDA.
Genmont functional probiotic passed oral health clinical trial and the results were published in an academic journal.
Genmont eN-Lac Probiotic capsules honored as China Health Food.
Anti-hyperglycemia effect of Genmont functional probiotic was published in an academic journal.
Lactobacillus paracasei GM-080 has recognized by FDA-NDI.
China new food ingredient approval— Lactobacillus fermentum GM-090.
ISO22000 and HACCP 2002 certificate.
Oral health care product“Bao-Yi-Kan g”won 2006 national innovate award and 2007 certificate of symbol of national quality.
Functional Probiotic GM-080 won Silver Award in the 2006 National Biotechnology & Medical Care Award.
Obtain the certificate of Food GMP.
Certified by the Department of Health to become the nation’s first manufacturing factory with the GMP certificate for active pharmaceutical ingredients (for probiotics production).
Genmont functional probiotic passed anti-allergy clinical trial and the results were published in an academic journal.
Ranked number 14 fastest growing technology company in the Deloitte TECH Fast 50 Taiwan, and number 2 in the biotech category, also number 50 in fast500 Asia pacific.
Public listing on OTC.
Obtained subsidies for the SBIR project.
Station in Tainan Science-based industrial park and built a factory.
Obtained factory registration certificate and business registration certificate.
GenMont Biotech Incorporation was founded in Taiwan.